Bob Broda

Editor’s note: Dr. Dennis Gillings is getting a big pay day as Quintiles prepares to go public. WRALTechWire asked Bob Broda, an expert on all things finance such as Sarbanes-Oxley and managing partner at Triangle-based Visage Solutions, to review Quilties’ last SEC filing about its IPO that could garner more than $900 million dollars, and offer his input about whether company co-founder and Chairman Dennis Gillings deserves such a big payday. We also asked him to comment on where Quintiles stands in the view of potential investors based on the latest data. Broad also assessed Quintiles’ initial IPO filing...

So what’s really going on at Quintiles, the world’s largest life science services firm that soon may go public again? On Friday, the RTP-based global conglomerate disclosed plans to drop its status as a privately held firm through a stock offering of an estimated $600 million. Finance expert Bob Broda, who leads RTPO-based Visage Solutions which is focused on compliance issues with an emphasis on Sarbanes-Oxley, reviewed the Quintiles filing at the request of WRAL Tech Wire and offers his views on where Quintiles stands plus where it seems to be headed. Broda’s analysis: I’m not necessarily an analyst...